PRKAA2 and nasopharyngeal carcinoma: The underlying molecular mechanism revealed to directly target the α1 catalytic subunit of AMP-activated protein kinase (AMPKα1) and consequently regulates the AMPK/mTOR/HIF1 pathway which ultimately leads to growth of NPC cells.